Bullfrog AI Holdings Inc. is a digital biopharmaceutical company that leverages artificial intelligence and machine learning to analyze complex datasets in medicine and healthcare. It offers bfLEAP, an analytical AI/ML platform designed to process preclinical and clinical data for biotechnology and pharmaceutical companies, identifying high-value patient subgroups and optimizing drug development and clinical trials. The company also provides bfPREP, a data preparation tool that harmonizes raw biomedical data into AI-ready formats, and bfARENAS, a scenario-based decision engine for generating risk-balanced R&D portfolio recommendations. Bullfrog AI Holdings Inc. supports precision medicine by uncovering treatment-effect heterogeneity and biomarkers, as demonstrated in applications like pancreatic cancer analytics and collaborations with partners in oncology trials. Founded in 2017 and headquartered in Gaithersburg, Maryland, it operates at the intersection of computational biology and AI to accelerate drug discovery, enhance clinical outcomes, and reduce development costs through explainable AI, graph analytics, and advanced modeling techniques.